ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
202.93
+0.2900
0.14%
盤後：
203.02
0.0900
+0.04%
19:37 EDT
成交量：
228.63萬
成交額：
4.65億
市值：
102.78億
市盈率：
32.15
高：
205.31
開：
203.94
低：
202.75
收：
202.64
52周最高：
217.12
52周最低：
138.79
股本：
5,065.00萬
流通股本：
5,065.00萬
量比：
1.60
換手率：
4.51%
股息：
0.41
股息率：
0.20%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.26
市盈率(LYR):
-135.83
資料載入中...
總覽
公司
新聞
公告
英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者
路透中文
·
09/01
英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor
美股速递
·
09/01
特朗普政府將宣佈藥品定價協議
路透中文
·
09/01
安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險
金吾财讯
·
08/31
藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI
新华财经
·
08/31
聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進
证券日报
·
08/30
台裕製藥提交針對HER2陽性乳腺癌的抗體藥物偶聯物生物類似藥TSY-110的臨床試驗申請。
智通财经
·
08/28
美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑
路透中文
·
08/28
美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群
美股速递
·
08/28
博濟醫藥2026年半年報：創新藥研發需求復甦，在手訂單充足，經營現金流明顯下滑
蓝鲸财经
·
08/27
英國股市——8月27日需關注的因素
路透中文
·
08/27
阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標
路透中文
·
08/27
Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標
美股速递
·
08/27
【券商聚焦】招銀國際維持藥明生物（02269）「買入」評級 指生物類似藥將成新驅動力
金吾财讯
·
08/27
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。
智通财经
·
08/21
Piper Sandler上調安進目標價至457美元
格隆汇
·
08/21
美國研究綜述-安進、Analog Devices、莫德納
路透中文
·
08/20
復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥
新浪港股
·
08/20
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/IBB/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.93,"timestamp":1789156800000,"preClose":202.64,"halted":0,"volume":2286306,"hourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"delay":0,"changeRate":0.0014311093564943766,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"休市中","change":0.29,"latestTime":"09-11 16:00:00 EDT","open":203.94,"high":205.31,"low":202.75,"amount":465174036.47682,"amplitude":0.012633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":202.867176,"aum":10356369334.8,"dividendRate":0.001997,"bidAskSpread":0.000338,"preHourTrading":{"tag":"盘前","latestPrice":204.63,"preClose":202.64,"latestTime":"09:25 EDT","volume":602,"amount":123106.38130000001,"timestamp":1789133112066,"change":1.99,"changeRate":0.00982,"amplitude":0.017917},"postHourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"volumeRatio":1.6013834487935477,"impliedVol":0.2368,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.6013834487935477,"shares":50650000,"dividePrice":0.4053,"high":205.31,"amplitude":0.012633,"preClose":202.64,"low":202.75,"week52Low":138.785,"pbRate":"1.26","psRate":"247.29","week52High":217.12,"institutionHeld":0,"latestPrice":202.93,"eps":6.311863,"divideRate":0.001997,"volume":2286306,"delay":0,"ttmEps":6.311863,"open":203.94,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.81,"twentyDayClose":198.94,"sixtyDayClose":171.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664347855","title":"英國監管機構因數據不可靠，暫停安進公司Tavneos用於新患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2664347855","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664347855?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 19:15","pubTimestamp":1788261324,"startTime":"0","endTime":"0","summary":"英国监管机构因数据不可靠，暂停安进公司Tavneos用于新患者路透9月1日-英国药品监管机构周二暂停了安进公司旗下AMGN.O研发的罕见病药物Tavneos对新患者的使用和销售，称支持该药获批的主要研究结果不可靠。监管机构表示，由于主要临床试验的数据不可靠，该研究已无法证明该药有效，也无法证明其益处大于风险。Tavneos由ChemoCentryx公司研发，安进公司于2022年以37亿美元收购了该公司。欧洲委员会于8月撤销了Tavneos的批准，此前监管机构发现其关键试验数据不可靠。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4T44T10B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","PBE","BK4566","IE00BJJMRZ35.SGD","LU2089984988.USD","BK7501","BBH","LU0122379950.USD","TBXU","LU1057294990.SGD","BK7511","BK4588","AMGN","BK7508","LU2468319806.SGD","SG9999001440.SGD","IBB","LU2242646821.SGD","LU2242652126.USD","LU0320765992.SGD","PJP","BK7067","BK4139","IE00B2B36J28.USD","LU0109394709.USD","IE0002141913.USD","LU2112291526.USD","CSL.AU","LU0889565916.HKD","BK4581","LU1983299246.USD","BK4533","BK4585","LU1061106388.HKD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0868494617.USD","BIB","BK4599","BK4534","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0289739699.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148791645","title":"英國藥品與健康產品管理局：通知上市許可持有方，自9月1日起暫停新患者使用、供應及銷售Avacopan Vifor","url":"https://stock-news.laohu8.com/highlight/detail?id=1148791645","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148791645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 17:35","pubTimestamp":1788255329,"startTime":"0","endTime":"0","summary":"英国药品与健康产品管理局（MHRA）已正式告知上市许可持有方，关于暂停Avacopan Vifor用于新患者的使用、供应及销售的相关决定。该措施自9月1日起生效。此番调整涉及该药物的市场流通环节，意在规范其临床应用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","PBE","PJP","AMGN","BK4534","LU1061106388.HKD","BK4599","BIB","BK4533","LU0109394709.USD","LU0320765992.SGD","LU1057294990.SGD","LU1571399168.USD","BBH","TBXU","LU1023059063.AUD","LU0868494617.USD","LU0889565916.HKD","BK4588","IBB","LU2468319806.SGD","LU0122379950.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","SG9999001440.SGD","BK4585","BK4566","BK4581","LU2242652126.USD","LU2242646821.SGD","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664002674","title":"特朗普政府將宣佈藥品定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2664002674","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664002674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-01 00:07","pubTimestamp":1788192474,"startTime":"0","endTime":"0","summary":"特朗普政府将宣布药品定价协议预计拜耳、武田、CSL以及中型生物技术公司将达成新协议路透此前曾报导，小型制药商认为参与其中的财务激励有限美国处方药价格往往是其他发达国家的近三倍路透8月31日-白宫一名官员表示，美国总统唐纳德·特朗普 预计将于周一宣布新一轮药品定价协议，这是旨在降低美国民众医疗保健成本举措的一部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4T44S1CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","LU2596442595.SGD","BK4550","GB00BDT5M118.USD","IE0004445015.USD","LU1868837300.USD","SG9999015952.SGD","LU2361044865.SGD","SG9999002224.SGD","THNR","IBB","IE00BFTCPJ56.SGD","LLII","LU1979441026.SGD","LU1623119135.USD","LU2028103732.USD","SGXZ81514606.USD","IE00B7KXQ091.USD","LU1267930730.SGD","IE00BLSP4452.SGD","BK4568","IE0001KFT4U8.USD","LU0158827948.USD","LU2237443465.HKD","SG9999002232.USD","IBBQ","BK7501","LU0256863902.USD","IE00B4R5TH58.HKD","LU2023250504.SGD","SG9999018857.SGD","SG9999011175.SGD","BIB","LU0306807586.USD","LU1571399168.USD","LU1814569148.SGD","OZEM","LU0889565916.HKD","CSL.AU","IE00BFSS7M15.SGD","LU0320765992.SGD","LU0345770308.USD","LU0708995401.HKD","LU1868836914.USD","ELIS","LU2089283258.USD","LU2746668461.USD","LU1035775433.USD","AMGN","LU0170899867.USD","LU1232071149.USD","IHE","BK7511","LU2360106947.USD","LU2750360641.GBP","SG9999014880.SGD","LU2242652126.USD","LU0289739699.SGD","IE0002141913.USD","LU0320765059.SGD","FTXH","LLYX","LU2264538146.SGD","LU0006306889.USD","CANC","LU0868494617.USD","LU2756315318.SGD","SG9999017495.SGD","IE00B19Z3B42.SGD","LU0456855351.SGD","IE00B4JS1V06.HKD","IE00BBT3K403.USD","IE00BJJMRZ35.SGD","IE00BJJMRY28.SGD","LU2236285917.USD","LU0683600562.USD","BK4139","LU0820562030.AUD","ILDR","LU1069344957.HKD","LU0097036916.USD","BK4592","LU1280957306.USD","IE00BWXC8680.SGD","LU1551013342.USD","LU2211815571.USD","LU1988902786.USD","LLY","IE00BK4W5M84.HKD","LU2023250330.USD","LU0353189763.USD","LU1720051017.SGD","IXJ","LU1057294990.SGD","LU0061475181.USD","LU0133085943.USD","BK4581","BK4534","LU0198837287.USD","LU2237443978.SGD","LU0266013472.USD","SG9999015986.USD","IE00B3T34201.USD","LU0786609619.USD","LU1093756168.USD","LU1974910355.USD","LU0114720955.EUR","LU1883839398.USD","LU1064131342.USD","BK4516","RXL","IE00BKPKM429.USD","LU2471134796.USD","LU2237443549.SGD","IE000M9KFDE8.USD","LU1989771016.USD","LU2602419157.SGD","LU2168564222.USD","LU2237443382.USD","SGXZ57979304.SGD","IE0009355771.USD","LU0882574055.USD","BK7508","BK4599","LU2168564065.EUR","LU0306806265.USD","LU2746668974.SGD","LU0321505439.SGD","LU0256863811.USD","LU2271345857.HKD","LU0385154629.USD","LU0466842654.USD","LU1323610961.USD","LU2106854487.HKD","LU2242646821.SGD","LU0234572021.USD","LU2750360997.AUD","LU2471134879.HKD","LU2491050071.SGD","JDOC","LU0079474960.USD","IONS","LU1894683264.USD","PFE","LU0174119429.USD","LU0238689110.USD","LU1917777945.USD","LU0823416689.USD","LU2023251221.USD","LU2237443622.USD","LU2491050154.USD","LU0882574139.USD","SG9999013999.USD","BK4007","LU0321505868.SGD","LU0820561909.HKD","LU0122379950.USD","IE00BLSP4239.USD","AGNG","LU1868836757.USD","LU2462157665.USD","LU2324357040.USD","LU0109394709.USD","LU0943347566.SGD","IE00BJJMRX11.SGD","LU0225284248.USD","SG9999014898.SGD","SG9999015978.USD","LU2361044949.HKD","LU0672654240.SGD","LU1720051108.HKD","LU2087625088.SGD","LU0353189680.USD","LU0471298777.SGD","LU0203201768.USD","LU0823434583.USD","ELIL","LU2756315664.SGD","IYH","BK4588","LU0432979614.USD","LU1066053197.SGD","IE00B2B36J28.USD","LU0820561818.USD","IE00B1BXHZ80.USD","LU2357305700.SGD","SGXZ51526630.SGD","LU0354030438.USD","VHT","LU1061106388.HKD","IE00BKDWB100.SGD","LU2265009873.SGD","LU1366192091.USD","LU0787776722.HKD","LU0345770993.USD","IE00BFSS8Q28.SGD","LU2471134952.CNY","LU0058720904.USD","LU1291159041.SGD","LU1868836591.USD","LU0823434740.USD","SGXZ31699556.SGD","LU2361045086.USD","LU2237438978.USD","LU2462591350.SGD","CURE","SG9999001176.SGD","LU2168563687.JPY","LU2896262040.SGD","LU1127390331.HKD","LU0096364046.USD","IE00BK4W5L77.USD","LU0109391861.USD","LU1868837136.USD","LU2089984988.USD","TRUH","LU0471298694.HKD","LU0094547139.USD","LU2168564495.EUR","BK7067","LU0106261372.USD","IE00B19Z3581.USD","LU2461242641.AUD","IE00B1XK9C88.USD","IE00BJLML261.HKD","LU2108987350.USD","SG9999001176.USD","SG9999003800.SGD","IE00B775H168.HKD","HRTS","LU0210536198.USD","LU2552382132.HKD","LU0225283273.USD","LU2213496289.HKD","LU2468319806.SGD","MEDX","SG9999015945.SGD","LU0323591593.USD","LU1023059063.AUD","WDNA","LU2168564149.EUR","LU1145028129.USD","LU1691799644.USD","FHLC","MHIP","LU1551013425.SGD","LU0985481810.HKD","SGXZ99366536.SGD","04332","LU2456880835.USD","BK4566","LLYZ","LU0964807845.USD","LU1712237335.SGD","SG9999018865.SGD","LU2111349929.HKD","LU1093756325.SGD","LU0158827781.USD","LU2471134523.USD","LU2552382215.SGD","LU0316494557.USD","LU0640476718.USD","PBE","SG9999001440.SGD","LU2112291526.USD","BK4585","TBXU","SG9999014906.USD","IE0005OL40V9.USD","IE0004445239.USD","BBH","PPH","IE00BJT1NW94.SGD","SG9999014914.USD","LU1894683348.USD","MEDI","LU2552382058.USD","LU0689472784.USD","LU1983299246.USD","LU2417539215.USD","GDOC","BK4533","IE00BN29S564.USD","LU0417517546.SGD","LU1629891620.HKD","LU2063271972.USD","TMED","XLV","LU0225771236.USD","LU2089284900.SGD","LU1804176565.USD","LU2237443895.HKD","PJP","IE0002270589.USD","LU1548497426.USD","LU1066051498.USD","LU0203202063.USD","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663778550","title":"安進（AMGN）降脂藥Repatha新臨床數據：可降低未發生心梗或中風高危患者20%死亡風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2663778550","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663778550?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 18:48","pubTimestamp":1788173287,"startTime":"0","endTime":"0","summary":"研究结果显示，对于既往未发生过心肌梗死或中风的高危成年患者，在接受他汀类或其他降脂疗法的基础上加用Repatha，可显著降低20%的全因死亡风险，同时有效降低心血管死亡率。数据显示，Repatha能在治疗开启最早6个月内降低心梗风险，且将患者低密度脂蛋白胆固醇中位数降低至45mg/dL，远优于安慰剂组的109mg/dL。此外，欧盟委员会已于2026年8月批准扩大Repatha在欧洲的适应症，用于确诊或高危确诊的动脉粥样硬化性心血管疾病成年患者降低心血管风险。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Mjk1NzA2YjQxMDg1MTQ0MjI1MzE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305491","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","BK4566","LU2242652126.USD","LU1057294990.SGD","LU0109394709.USD","LU0868494617.USD","BK4581","LU1061106388.HKD","BK4588","BBH","PBE","BK4139","BIB","LU2242646821.SGD","TBXU","BK4585","LU0058720904.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0289739699.SGD","IBB","LU2089984988.USD","IE00BJJMRZ35.SGD","PJP","BK4599","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE0009355771.USD","LU0122379950.USD","LU1983299246.USD","BK4534","LU2112291526.USD","LU1571399168.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4533","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电（记者杜康）作为AI制药领域代表性企业之一，英硅智能（03696.HK）日前发布2026年度中期业绩报告。上半年，公司实现总营收1.063亿美元，同比增长287.2%；净利润3554万美元，经调整净利润5123万美元，经营活动现金流转正。这是英硅智能上市后发布的首份半年报，公司也由此前的亏损转为盈利。从收入结构看，药物研发与管线开发仍是主要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["AGIX","BK4588","ARTY","BIOY","CHAT","BK4585","GDOC","LFSC","WRND","GSKH","AIPO","PBE","SBIO","XLVI","IBB","APXH","VTHR","IPOS","QTOC","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年，联环药业经营业绩实现明显改善。对此，联环药业正持续推进相关工作。值得注意的是，联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外，联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售，到集采品种持续放量，再到创新药研发向上市申报环节推进，联环药业正在逐步形成多层次的业务增长支撑。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4588","GDOC","BIOY","GSKH","BBP","600513","IBB","WRND","PBE","XLVI","BK0239","APXH","LFSC","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662060177","title":"台裕製藥提交針對HER2陽性乳腺癌的抗體藥物偶聯物生物類似藥TSY-110的臨床試驗申請。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662060177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662060177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:03","pubTimestamp":1787918605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PPH","LU2272731865.HKD","BMED","BK4585","IBBQ","IBB","BK4588","XPH","IBBJ","MDTX","LU2322448957.HKD","IE00B5TLWC47.USD","LU1992135472.HKD","LU2272731782.SGD","LU1992135399.USD","LU2272731600.USD","LU2473716301.USD","LU2322448791.USD","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036374","title":"美國食品藥品監督管理局（FDA）批准吉利德治療艾滋病的每日一次複方片劑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036374","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036374?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867453,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）批准吉利德治疗艾滋病的每日一次复方片剂路透8月27日-吉利德科学公司周四表示，美国食品和药物管理局已批准该公司研发的每日一次口服复方药GILD.O，用于治疗HIV病毒载量已降至极低水平的成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4S44O24V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU0861579265.USD","LU2112291526.USD","LU0889565916.HKD","LU2324357040.USD","IE00B7SZLL34.SGD","BK4532","BK4583","GILD","BK4568","IE00B3T34201.USD","SG9999015986.USD","BMED","BBH","LU0965509283.SGD","IBBQ","LU0289739699.SGD","TBXU","LU1061106388.HKD","BK4566","MEDI","IE0002270589.USD","LU1674673691.USD","LU1934455277.USD","SG9999015952.SGD","SG9999015945.SGD","LU0114720955.EUR","TMED","BIB","IBB","LU1037948541.HKD","LU0109394709.USD","LU1023059063.AUD","SG9999015978.USD","BK4139","LU1839511570.USD","IE00B19Z3581.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0965508806.USD","LU1430594728.SGD","LU1778281490.HKD","BK4585","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD","LU1571399168.USD","LU0965509101.SGD","LU0058720904.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198194055","title":"美國FDA批准吉利德科學Bixlenvo™上市：每日單片方案為病毒學抑制HIV成人患者提供新選擇，涵蓋複雜治療方案人群","url":"https://stock-news.laohu8.com/highlight/detail?id=1198194055","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198194055?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 05:49","pubTimestamp":1787867358,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局正式批准了吉利德科学旗下新药Bixlenvo。这款每日一次的单片制剂，专为病毒学抑制状态的HIV成人感染者设计——即便是那些正在接受复杂治疗方案的病患，也适用这一新选项。此项获批标志着HIV治疗领域又添一枚重要砝码。Bixlenvo以单片复方形式呈现，将给药频率与用药负担同步压缩，患者无需再面对繁琐的多药组合。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","BK4566","LU0320765992.SGD","LU0965509101.SGD","IBBQ","LU0965509283.SGD","LU0109394709.USD","SG9999015952.SGD","LU1934455863.HKD","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","SG9999015978.USD","LU0122379950.USD","LU2089984988.USD","BK4583","BBH","BK4585","LU0289739699.SGD","LU1839511570.USD","BK4568","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU1057294990.SGD","LU1037948541.HKD","LU1061106388.HKD","SG9999015945.SGD","IE00B19Z3B42.SGD","LU0859254822.USD","GILD","LU1778281490.HKD","LU0823416689.USD","BK4139","IE00BZ1G4Q59.USD","LU1934455277.USD","LU2357627491.SGD","BK4532","TBXU","LU1066053197.SGD","MEDI","BMED","LU0114720955.EUR","LU2112291526.USD","LU1571399168.USD","LU2324357040.USD","LU0965508806.USD","LU1430594728.SGD","LU0882574055.USD","LU1023059063.AUD","BK4550","LU2468319806.SGD","IE00BKVL7J92.USD","TMED","LU1037948897.HKD","LU0965509010.AUD","BK4578","LU0861579265.USD","LU2087621335.USD","LU1066051498.USD","BK4588","LU1674673428.USD","LU1934455194.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU0234570918.USD","IE00B7SZLL34.SGD","IE00B3T34201.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752987","title":"博濟醫藥2026年半年報：創新藥研發需求復甦，在手訂單充足，經營現金流明顯下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752987","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662752987?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:57","pubTimestamp":1787813849,"startTime":"0","endTime":"0","summary":"然而，需警惕新药研发政策变化、项目执行延期及市场竞争加剧带来的风险，同时关注经营现金流与净利润背离的情况。后续需重点关注公司在手订单转化进度、临床前及临床研究服务的毛利率变化趋势，以及经营现金流的改善情况。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787797151251328663","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SBIO","LFSC","159399","BK4585","WRND","BK0216","BIOY","SPHQ","APXH","IBB","PBE","XLVI","GSKH","BBP","300404","GDOC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导，更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开，期货FFIc1下跌0.4%。*7月汽车产量：行业数据显示，受出口疲软及部分工厂提前进行夏季检修停产影响，英国7月汽车产量 同比下降11.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0047713382.USD","LU0553294199.USD","LU0075056555.USD","CRDA.UK","LU1267930227.SGD","LU0969580561.USD","LU2089984988.USD","HFD.UK","BK5105","LU1355424745.HKD","GAW.UK","LU1267930573.SGD","BBH","PPH.UK","AZN.UK","LU0171293334.USD","03165","LU0949170426.SGD","LU0889565916.HKD","BK4585","LU0345780950.USD","IE0034235188.USD","LU1880407132.USD","TBXU","LU1119994496.HKD","LU0211326755.USD","LU0857590862.USD","LU0310800379.SGD","LU1104425308.USD","IBBQ","SG9999001176.SGD","LU0963555726.SGD","SGXZ57979304.SGD","BK4139","IBB","LU0122379950.USD","LU2293690082.USD","LU1989772923.USD","LU0171276677.USD","LU0345777147.USD","LU1989771016.USD","PJP","LU0792757196.USD","PRU.UK","BIB","LU1057294990.SGD","LU0868494617.USD","PBE","GLEN.UK","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康（AstraZeneca）AZN.L周四表示，其与安进（Amgen）AMGN.O联合开发的哮喘药物Tezspire，在治疗嗜酸性粒细胞性食管炎（一种食管的慢性炎症性疾病）的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","LU0949170426.SGD","LU0171276677.USD","BK5011","BIB","LU0011850046.USD","LU0203345920.USD","LU2237443549.SGD","LU1015430645.USD","LU0882574055.USD","LU1119994496.HKD","AMGN","LU2125909247.SGD","BK4139","LU2089284900.SGD","IBB","LU1273509221.SGD","LU1061106388.HKD","TBXU","PBE","AZN.UK","LU0432979614.USD","03165","LU1323610961.USD","LU2357627491.SGD","LU0889565916.HKD","IE00B2B36J28.USD","BBH","LU0211327993.USD","IE00BFTCPJ56.SGD","LU0211328371.USD","IBBQ","BK4588","BK4599","LU0757432116.USD","LU0390134368.USD","LU1267930813.SGD","LU1989772840.SGD","LU1196032939.SGD","PJP","LU1261432733.SGD","LU0158827948.USD","LU1064927863.SGD","LU1481599808.USD","LU0496365809.HKD","LU0960981461.USD","LU0640478417.SGD","LU0526926950.USD","LU0557290698.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点，而且所有关键次要终点也悉数告捷。Tezspire的优异表现，标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成，以及关键次要终点的全面覆盖，充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出，Tezspire的这项研究成果，不仅巩固了其在炎症性疾病治疗领域的地位，更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","IE0009355771.USD","LU1571399168.USD","BK4566","BK4533","IE0002141913.USD","IE00BFTCPJ56.SGD","IBBQ","LU2089984988.USD","BK4581","LU2112291526.USD","IBB","LU0058720904.USD","LU0320765992.SGD","LU1023059063.AUD","BBH","BK4534","BIB","IE00BJJMRZ35.SGD","PBE","LU0109394709.USD","AMGN","LU1061106388.HKD","LU1057294990.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","SG9999001440.SGD","LU2242652126.USD","BK4139","BK4588","BK4599","LU0122379950.USD","LU0868494617.USD","LU2242646821.SGD","TBXU","LU2468319806.SGD","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778813","title":"【券商聚焦】招銀國際維持藥明生物（02269）「買入」評級 指生物類似藥將成新驅動力","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778813","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778813?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 13:20","pubTimestamp":1787808047,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，药明生物 2026年上半年业绩强劲，收入同比增长18.4%至人民币118亿元，经调整净利润增38.4%至33亿元。毛利率升至46.2%，总积压订单达251亿美元。生物类似药将成M端新支柱。公司已有17个生物类似药项目，未来三年已承诺20个项目，80%客户来自全球前十企业。维持“买入”评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989738","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","02269","PPH","IBB","XPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1066053197.SGD","TMED","BK4566","LU2089984988.USD","LU2324357040.USD","BK4578","BBH","LU0122379950.USD","SG9999015952.SGD","TBXU","LU1057294990.SGD","BMED","BK4588","LU2468319806.SGD","BK4568","LU1934455863.HKD","LU0965509010.AUD","IBB","IE00B7SZLL34.SGD","LU1839511570.USD","BK4550","LU0320765992.SGD","IE00BSNM7G36.USD","BK4139","LU0114720955.EUR","LU0109394709.USD","LU0859254822.USD","LU1585245621.USD","LU1674673691.USD","LU2087621335.USD","LU2112291526.USD","IE00B19Z3581.USD","SG9999015978.USD","IE00BKVL7J92.USD","LU1037948541.HKD","LU0823416689.USD","LU0234570918.USD","LU0889565916.HKD","LU1934455277.USD","LU1934455194.USD","LU0882574055.USD","LU2357627491.SGD","BK4585","LU1061106388.HKD","LU1037948897.HKD","LU0861579265.USD","LU0965508806.USD","LU1571399168.USD","IBBQ","LU0058720904.USD","LU0965509101.SGD","LU0965509283.SGD","BIB","IE00B19Z3B42.SGD","BK4583","LU1674673428.USD","SG9999015986.USD","LU1430594728.SGD","BK4532","LU1023059063.AUD","LU1066051498.USD","LU1778281490.HKD","MEDI","GILD","LU0289739699.SGD","SG9999015945.SGD","IE00B3T34201.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","IBBQ","LU0889565916.HKD","LU1066053197.SGD","SG9999015978.USD","LU0965509283.SGD","TBXU","IE00B7SZLL34.SGD","LU1037948897.HKD","GILD","IE0002270589.USD","LU0965509101.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1674673691.USD","BMED","LU0861579265.USD","LU1934455277.USD","LU0965509010.AUD","BK4532","LU1778281490.HKD","LU0320765992.SGD","BK4566","BK4568","LU1430594728.SGD","BK4139","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965508806.USD","LU1023059063.AUD","LU2087621335.USD","LU0882574055.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BBH","IBB","LU0058720904.USD","BK4583","LU1674673428.USD","LU1934455863.HKD","LU1037948541.HKD","LU1839511570.USD","LU2112291526.USD","SG9999015952.SGD","LU0109394709.USD","LU2089984988.USD","LU0859254822.USD","BK4578","MEDI","LU2468319806.SGD","LU1934455194.USD","IE00B3T34201.USD","BK4550","SG9999015986.USD","TMED","LU0122379950.USD","LU1571399168.USD","BK4585","LU1057294990.SGD","LU0823416689.USD","BK4588","LU0289739699.SGD","LU0234570918.USD","BIB","LU1061106388.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BBH","IXP","RSPT","HCA","JHMT","NBDS","KEMQ","TDAQ","TRUC","BUYO","DISC","PJP","PBE","TGRW","AMGN","IEME","NBCC","MSFY","GOOX","LRGG","QQMG","XLCI","ORCZ","IBB","MSFX","EMQQ","GXPC","WEBX","FCOM","ONEQ","FTC","WEBL","MNA","BIB","GXPT","CWC","EVNT","ARB","JHCS","MRGR","TBXU","GGTL","IHF","IBBQ","BWEB","DRUP","PBS","BCTK","MUSQ","PNQI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2468319806.SGD","LU0122379950.USD","IBB","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","UDN","BK4581","BK4534","IBBQ","IE00B4R5TH58.HKD","BK4566","BK4588","IE00B2B36J28.USD","BIB","LU1571399168.USD","LU0889565916.HKD","LU0320765992.SGD","PBE","LU1061106388.HKD","SG9999001440.SGD","AMGN","LU0058720904.USD","LU2112291526.USD","BK4585","IE0009355771.USD","LU2242652126.USD","LU0289739699.SGD","IE0002141913.USD","TBXU","BK4599","BBH","IE00BJT1NW94.SGD","LU0868494617.USD","LU1983299246.USD","LU2242646821.SGD","BK4533","LU2089984988.USD","PJP","UUP","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1119994496.HKD","LU0690374961.EUR","IE0009355771.USD","SG9999014542.SGD","WISE","LU2237443622.USD","LU0472753341.HKD","IE00B19Z9Z06.USD","LU2089985449.USD","CRWC","FXL","ARTY","LU1674673691.USD","LU1496350502.SGD","LU2491049909.HKD","LU1066053197.SGD","IE00BMPRXN33.USD","IE00B2B36J28.USD","LU2458330243.SGD","BK4185","MRNY","SNOU","LU2360107168.USD","MRVX","LU1670710661.SGD","LU0289739699.SGD","LU2506952097.USD","LU0795875086.SGD","LU0950375773.USD","LU2357627491.SGD","LU0094547139.USD","LU1023059063.AUD","LU2404859741.USD","LU2324357040.USD","LU2129689431.USD","LU1983299246.USD","LU2298321311.HKD","LU0889565833.HKD","VHT","BILL","IE00B5949003.HKD","LU0689626769.HKD","WCBR","LU1823568750.SGD","GLAM","LU2322448957.HKD","LU0056508442.USD","TJX","LU1670627923.USD","LU0823434740.USD","LU0312595415.SGD","04332","LU2237443549.SGD","IGV","SG9999000418.SGD","LU0823417737.USD","LU1267930490.SGD","TBXU","LU2468319806.SGD","SPAM","LU0689472784.USD","LU2087621335.USD","LU1923622614.USD","MRNA","LU1064131342.USD","LU0868494617.USD","LU2360106780.USD","LU1150488135.SGD","SNOY","LU2491050071.SGD","LU1934455863.HKD","BK4528","LU0128525689.USD","BK4533","LU2023250504.SGD","LU2322448791.USD","IE00B3S45H60.SGD","IE00BVYPNW00.USD","LU0302445910.USD","LU0320765646.SGD","LU1623119135.USD","LU2506951958.HKD","BK4585","MVLL","DAT","LU0265550946.USD","BK4551","IE00BLSP4239.USD","LU0912757837.SGD","LU0965509010.AUD","LU0943347566.SGD","FDTX","LU2098885051.SGD","GNOM","AGNG","LU0708994859.HKD","LU0980610538.SGD","LU0211327993.USD","LU1839511570.USD","LU0211328371.USD","LU0949170772.SGD","SG9999014013.SGD","LU0823417653.USD","CLOD","IE00BN8TJ469.HKD","SG9999014039.USD","LU0878866978.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU0444973449.USD","CLOU","LU1718418525.SGD","SG9999014021.USD","LU2125154778.USD","LU0320765992.SGD","LU0006306889.USD","LU0882574055.USD","LU0130102774.USD","LU0476273544.USD","LU2237443382.USD","LU2041044095.USD","LU0417517546.SGD","LU2272731865.HKD","IE00BD6J9T35.USD","IBB","LU0310799852.SGD","LU0274383776.USD","LU0823421333.USD","LU1861220033.SGD","LU0081259029.USD","LU0724618433.USD","LU0128525929.USD","RXL","LU1720051017.SGD","LU2237443978.SGD","LU1551013342.USD","LU1169590202.USD","LU2242646821.SGD","SG9999015341.SGD","SG9999015978.USD","BK4607","LU1116320901.HKD","LU2543165471.USD","LU0256863902.USD","LU1571399168.USD","LU2290526834.HKD","LU0256863811.USD","LU1670628061.USD","LU1674673428.USD","LU0456855351.SGD","LU0957808578.USD","LU1201861249.SGD","LU1642822529.SGD","BK4114","LU0823421416.USD","SG9999001176.SGD","LU1720051108.HKD","LU2089283258.USD","BK4504","LU0124676726.USD","IE000SO60NU8.SGD","LU1935042991.SGD","BK4535","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0069063385.USD","LU1267930573.SGD","LU0070302665.USD","IXJ","LU0211331839.USD","BK4554","HCA","LU1804176565.USD","LU0068578508.USD","LU0432979614.USD","LU2244417387.USD","LU2552382058.USD","LU2491050154.USD","IBBQ","LU2361045086.USD","LU2237443895.HKD","LU2433249047.HKD","LU2347655156.SGD","LU2355687059.USD","IE0004086264.USD","LU2133065610.SGD","LU2361044949.HKD","LU2552382132.HKD","LU0859254822.USD","IE0004091025.USD","SG9999014575.USD","LU0310800379.SGD","BK4599","LU1066051498.USD","LU1066051811.HKD","LU0965509101.SGD","TRUH","LU1061106388.HKD","LU1691799644.USD","IE0009356076.USD","LU2361044865.SGD","LU1732799900.SGD","LU1941712264.USD","LU1861214812.USD","IE00BZ1G4Q59.USD","IE00B4R5TH58.HKD","SG9999015358.SGD","LU1551013425.SGD","HAKY","LU1992135472.HKD","WDNA","IE0004445239.USD","BK4155","BUG","LU0158827948.USD","LU1585245621.USD","LU0052756011.USD","BK4560","BK4559","LU2458330169.SGD","LU0058720904.USD","LU0154236417.USD","BK4516","LU2242652126.USD","LU1989771016.USD","IE00B19Z3B42.SGD","LU0444971666.USD","BK4596","BK4597","LU0210528500.USD","LU0077335932.USD","LU1712237335.SGD","LU0823411888.USD","LU0203345920.USD","LU1852331112.SGD","BK4141","LU2112291526.USD","LU2129689514.USD","SG9999011175.SGD","SOXY","LU1978683503.SGD","LU0985489474.SGD","LU1244550577.SGD","LU2125909916.SGD","LU0726765562.USD","LU0820561818.USD","BK4592","LU0648001328.SGD","LU0098860793.USD","LU1974910355.USD","LU2517655291.USD","IE00BKVL7J92.USD","BK4512","LU2404859667.USD","LU2506951875.HKD","LU1941712348.USD","LU1989764748.USD","FHLC","LU0942090050.USD","LU0314106906.USD","PPH","LU1923622291.USD","LU0965508806.USD","IE00B894F039.SGD","LU1548497426.USD","LU1815336760.USD","WUGI","LU0029864427.USD","LU0238689110.USD","LU0109392836.USD","MRVL","LU1489326972.SGD","LU1989763005.USD","MEDX","BK4130","LU0124384867.USD","BK4501","LU0661504455.SGD","LU1917777945.USD","LU0130517989.USD","BK4139","IE000WAW04H5.SGD","FTXL","LU1951200564.SGD","QQQA","LU0786609619.USD","LU0265550359.USD","LU0642271901.SGD","SGXZ57979304.SGD","IE00BZ9MQY76.HKD","IDNA","LU2250418816.HKD","DTCR","AIS","LU1929549753.HKD","LU0795875169.SGD","LU1035773651.USD","LU0861579265.USD","BK4568","LU2089284900.SGD","LU1267930227.SGD","BIB","IE0000B7K699.USD","IE00BJT1NW94.SGD","LU0553294199.USD","LU2360107325.USD","FAI","LU1951198990.SGD","LU1934455194.USD","SG9999015986.USD","LU0109394709.USD","LU2129689605.HKD","LU1093756168.USD","LU0820561909.HKD","BK4532","LU1235294995.USD","LU0187121727.USD","CRWD","LU1046421795.USD","WDAY","SG9999014559.SGD","LU1732800096.USD","XLV","LU1923623000.USD","BK4613","LU0106261372.USD","LU2347655073.USD","SG9999014567.USD","XNTK","LU1935043536.SGD","LU0395794307.EUR","SNOW","IE000M9KFDE8.USD","IE00B19Z9P08.USD","AIFD","IE00BBT3K403.USD","SG9999003800.SGD","IE00B1BXHZ80.USD","LU0289961442.SGD","LU1778281490.HKD","LU2461242641.AUD","BK4581","IE0002270589.USD","LU0289739343.SGD","LU2237443465.HKD","SG9999001176.USD","BK4094","IE0034235188.USD","PSWD","IE00B775SV38.USD","LU1989764664.SGD","SG9999015945.SGD","LU0965509283.SGD","LU1116320737.USD","LU2275660780.HKD","LU0823416689.USD","LU0097036916.USD","BK4515","BK4566","PBE","LU1066051225.USD","LU2125154935.USD","LOW","ABBV","LU2023250843.SGD","LU1303367103.USD","TGT","BK4548","LU1162221912.USD","MRK","LU1989772923.USD","IE00B19Z3581.USD","LU2272731600.USD","SG9999002224.SGD","LU2092937221.SGD","IE00B42XCP33.USD","IHE","SG9999001440.SGD","BK4561","LU1670711123.USD","EL","LU2552382215.SGD","IE00B5TLWC47.USD","LU0738911758.USD","LU1803068979.SGD","LU2298322129.HKD","LU2357305700.SGD","LU2264538146.SGD","BK4503","LU0320765489.SGD","LU1861215975.USD","LU0203347892.USD","IYH","LU1037948541.HKD","LU1037948897.HKD","LU2125909593.SGD","SG9999013999.USD","LU0477156953.USD","LU2360108059.USD","LU0127658192.USD","LU0985320562.USD","LU1291159041.SGD","BK4097","GTEK","ADI","LU2506952170.USD","LU0170899867.USD","IE000MB6IJN5.SGD","BBH","LU2211815571.USD","LU0234570918.USD","LU2106854487.HKD","AMGN","SMHX","IE00BVYPNV92.GBP","LU1496350171.SGD","XDAT","LU1169589451.USD","LU0053666078.USD","LU1506573853.SGD","LU1316542783.SGD","LU0266013472.USD","PAWZ","BK4588","LU0823434583.USD","SG9999014005.SGD","LU2272731782.SGD","LU1670710588.SGD","PJP","LU0082616367.USD","LU0690374615.EUR","LU2286300806.USD","LU1244550221.USD","LU1670711040.USD","LU0198837287.USD","LU1989772840.SGD","BK4007","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0208291251.USD","IE00B3PB1722.GBP","LU1261432733.SGD","LU1989773731.SGD","IE000F7OJYX1.SGD","LU2487616109.SGD","LU1992135399.USD","LU1150488218.USD","BK4550","LU0310800965.SGD","BK4116","AIPI","JDOC","BK4083","CIBR","BK4183","LU0061475181.USD","LU2931357623.SGD","IE00BGHQF631.EUR","SG9999015952.SGD","LU2517655028.SGD","LU0234572021.USD","LU1074936037.SGD","LU2089984988.USD","LU1430594728.SGD","BMED","LU1069347547.HKD","HRTS","BK4604","IE00BMPRXR70.SGD","LU1003077747.HKD","LU0122379950.USD","LU2265009873.SGD","LU0114720955.EUR","LU2125909247.SGD","IE00BMPRXQ63.HKD","LU1861219969.SGD","GDOC","LU1699723380.USD","IE00BLSP4452.SGD","IE00BDGV0183.EUR","LU0545039389.USD","LU2125909759.SGD","LU0433182093.SGD","BK4505","MRNX","PCTY","BK4543","BK4534","IE0002141913.USD","BK4023","BK4598","LGHT","CRWL","LU1988902786.USD","LU1934455277.USD","LU2517655374.HKD","BK4558","WOLF","LU0868494708.USD","LU2237438978.USD","LU2360032135.SGD","LU2023251221.USD","LU1084165304.USD","BK4605","IE00BZ199S13.USD","LU0057025933.USD","LU1244550494.USD","IHF","FTXH","LU2473716301.USD","MRVU","LU0719512351.SGD","IE000BZT7R73.USD","LU0314104364.USD","LU0511384066.AUD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747701","title":"復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747701","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747701?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:56","pubTimestamp":1787194560,"startTime":"0","endTime":"0","summary":"模拟交易客户端复宏汉霖盘中涨近8%，截至发稿，股价上涨6.87%，现报70.05港元，成交额1646.58万港元。基于上述首批约定，山德士将向复宏汉霖支付首付款、相关里程碑付款及不可退还的选择权费共计至高3.22亿美元；2026年，复宏汉霖预计可达成的开票金额总计不超过1.005亿美元。值得一提的是，海外市场已成为复宏汉霖业绩增长的重要组成部分。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxw2099208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XPH","HK0000165453.HKD","IBB","LU1992135399.USD","LU1992135472.HKD","HK0000320264.USD","LU2272731865.HKD","IE00B5TLWC47.USD","LU2272731600.USD","HK0000306685.HKD","02696","BK4585","PPH","LU2322448957.HKD","HK0000320223.HKD","HK0000306701.USD","BK4588","BK1161","LU2272731782.SGD","LU2322448791.USD","LU2473716301.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}